Hereditary Hemorrhagic Telangiectasia : More Than a Nosebleed
WebcastFaculty
OVERVIEW
Hereditary Hemorrhagic Telangiectasia : More Than a Nosebleed is organized by David Geffen School of Medicine at University of California, Los Angeles (UCLA) and will be held during Feb 08, 2016 - Feb 07, 2018. This CME Conference has been approved for a maximum of 1.0 AMA PRA Category 1 Credits.
Hereditary hemorrhagic telangiectasia (HHT) has a disease incidence similar to cystic fibrosis, but is much less well known. Dr. Justin McWilliams provides an overview of the pathophysiology, diagnosis, and treatment of HHT.
Conference Objectives are :
At the conclusion of this activity, participants should be able to:
• Diagnose a patient with hereditary hemorrhagic telangiectasia.
• Manage the patient with HHT and nose bleeds.
• Appropriately screen patients with HHT for stroke, lung AVM’s, and other serious outcomes.
Additional details will be posted as soon as they are available.
Hereditary hemorrhagic telangiectasia (HHT) has a disease incidence similar to cystic fibrosis, but is much less well known. Dr. Justin McWilliams provides an overview of the pathophysiology, diagnosis, and treatment of HHT.
Conference Objectives are :
At the conclusion of this activity, participants should be able to:
• Diagnose a patient with hereditary hemorrhagic telangiectasia.
• Manage the patient with HHT and nose bleeds.
• Appropriately screen patients with HHT for stroke, lung AVM’s, and other serious outcomes.
Additional details will be posted as soon as they are available.
SPECIALITIES
Emergency MedicineDermatologyRemedialRELATED ONLINE COURSES
Quick Links